Chalfont St Giles, UK -- 2 February 2012 -- GE Healthcare Life Sciences today announced the winners of 2011 IN Cell Analyzer Image Competition. Geoffrey Grandjean from the United States, Marie Neguembor from Italy, and Lesley Caron from Australia, each took first place in a regional category. The winning images will be displayed on NBC Universal's high-definition screen in Times Square, New York at a special event held April 20-22 2012.
business unit
tags
Mexico, D.F. February 1, 2012--GE Healthcare introduced today in Mexico the pocket-sized, portable visualization tool, Vscan*, a device that enables physicians to quickly look inside the body at the point of care.
business unit
tags
GE Healthcare's Discovery NM 750b is a specialized breast scanner that enables advanced functional imaging of breast cancer
Hopewell Township, NJ and Waukesha, WI January 30, 2011 ---Capital Health and GE Healthcare announced today the first Discovery* NM 750b was installed at Capital Health's New Jersey Hopewell medical center. Capital Health is a central New Jersey region leader in advanced medicine, with significant investments in advanced technologies and its medical staff.
business unit
tags
GE Healthcare, Chalfont St Giles, UK - Jan 25th 2012 - GE Healthcare's Discovery CT750 HD, the world's first high-definition CT system, has been included in the first fully positive recommendation from the National Institute for Health and Clinical Excellence (NICE)'s Diagnostic Assessment Programme which aims to ensure the National Health Service (NHS) can rapidly and consistently adopt clinically and cost effective technologies.
business unit
tags
Miami, FL -- January 17, 2012-- Data presented at the 6th Annual Human Amyloid Imaging (HAI) meeting in Miami suggest that the investigational imaging agent [18F] Flutemetamol could add value to current diagnostic tools used by physicians to evaluate neurodegenerative conditions like Alzheimer's Disease (AD). [18F]Flutemetamol is a GE Healthcare PET imaging agent in phase III development for the detection of beta amyloid.